विदेश

* Consul general warned against contact with 'anti-China forces' * U.S. diplomat ran afoul of China in first Trump administration * Trump due to meet Chinese leader this month for key trade talks (Adds no response from Chinese Foreign Ministry in paragraph 10) WASHINGTON, Oct 2 (Reuters) – The U.S. State Department on Thursday brushed off a statement from the senior Chinese diplomat in Hong Kong warning the recently appointed U.S. consul general there not to interfere in the affairs of the Chinese-ruled city. "U.S. diplomats represent our nation and are charged with advancing U.S. interests globally, which is standard practice for diplomats around the world including in Hong Kong," a senior State Department official said in a statement in response to the remarks about the consul-general, Julie Eadeh. Cui Jianchun, China's top diplomat in Hong Kong, issued a statement earlier on Thursday, saying he met Eadeh on Tuesday "to lodge solemn representations on her conducts (sic) since she assumed duties." The statement, published on the website of Cui's office, urged Eadeh "to abide by fundamental norms governing international relations including non-interference in domestic affairs and make a clean break with anti-China forces." It said Cui explicitly stated the "Four Don'ts" requirements, "namely don't meet the people who the CG shouldn't meet with, don't collude with anti-China forces, don't instigate, assist, abet or fund any activities that undermine stability in Hong Kong, don't interfere with national security cases in Hong Kong." Eadeh, who took up the post of consul general in August, ran afoul of Chinese authorities in 2019, during the first administration of U.S. President Donald Trump, when official Chinese media criticized U.S. diplomats for contacts with student leaders of protests that were then convulsing the city. The Hong Kong newspaper Ta Kung Pao published a photograph of a U.S. diplomat, whom it identified as Eadeh, who was then with the consulate's political section, talking with student leaders in the lobby of a luxury hotel. The State Department at the time criticized Chinese authorities for leaking photos of a diplomat and their children's names, calling this the actions of a "thuggish regime" that had gone from "irresponsible to dangerous." The current exchange comes at a sensitive time for U.S.-China relations, with Trump seeking to conclude a major trade deal with Washington's biggest economic and geopolitical rival and due to meet his counterpart Xi Jinping toward the end of the month. The Chinese Foreign Ministry did not immediately respond to a Reuters request for comment on Friday. (Reporting by David Brunnstrom and Simon Lewis in Washington; additional reporting by the Beijing newsroom; Editing by Matthew Lewis and Kate Mayberry)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Oct 3 (Reuters) – NZX Ltd: * SEPT TOTAL MARKET CAPITALISATION NZ$246,311 MILLION * SEPT CASH MARKET TOTAL VALUE TRADED NZ$3,823 M * SEPT TOTAL DERIVATIVES LOTS TRADED 89,952 UNITS Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Oct 3 (Stats Perform) – Results from the NHL games on Thursday (home team in CAPS) New Jersey 3 NY RANGERS 1 NY Islanders 4 PHILADELPHIA 3

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Oct 3 (Reuters) – Vault Minerals Ltd: * PRELIMINARY Q1 FY26 GOLD SALES WERE 91,477 OUNCES Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

FIFA's vice president said soccer's global governing body decides whether to move 2026 World Cup matches from host cities, contrary to comments made Sept. 25 by President Donald Trump. Speaking last week about the event, which will be co-hosted by the U.S., Canada and Mexico from June 11 to July 19, Trump was asked by reporters in the Oval Office specifically about games in Seattle and San Francisco. "Well, that's an interesting question … but we're going to make sure they're safe," he said. "(Seattle and San Francisco are) run by radical left lunatics who don't know what they're doing. "If I think it's not safe, we're going to move it out of that city. So if any city we think is going to be even a little bit dangerous for the World Cup, or for the (2028) Olympics … but for the World Cup in particular, because they're playing in so many cities, we won't allow it. We'll move it around a little bit. But I hope that's not going to happen." Six matches are scheduled to be played at Seattle's Lumen Field and six are set for Levi's Stadium in Santa Clara, Calif., about an hour's drive from San Francisco. Atlanta, Boston, Dallas, Houston, Kansas City, Los Angeles, Miami, Philadelphia and New York/New Jersey (East Rutherford) are also host cities in the United States. Victor Montagliani, the organization's vice president, said during a conference in London on Wednesday that FIFA determines game sites. "It's FIFA's tournament, FIFA's jurisdiction, FIFA makes those decisions," Montagliani said. "With all due respect to current world leaders, football is bigger than them and football will survive their regime and their government and their slogans. That's the beauty of our game, that it is bigger than any individual and bigger than any country." FIFA first established its World Cup host city plan in 2022, with specific games assigned in February 2024, including the final at MetLife Stadium in East Rutherford, N.J. Making changes would create logistical and legal issues, made potentially more difficult because FIFA tournaments depend on local and national governments for support with matters such as visa processing and security measures. Gianni Infantino, FIFA's president, has publicly appeared with Trump numerous times as the organization has developed a closer relationship, including establishing an office in Trump Tower in New York. The final draw for the 2026 World Cup, which will feature 48 teams, is slated for Dec. 5 at Washington's Kennedy Center, over which Trump has taken control as its board chairman. –Field Level Media

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

NFL commissioner Roger Goodell announced the league will return to Mexico City in 2026, confirming the next game at Estadio Azteca, as the venue nears completion of its World Cup renovation. "We'll be back in Mexico City next year, which we're thrilled about," the commissioner said at the Leaders in Sport conference in London, marking the league's first on-the-record timetable for a Mexico game since the stadium closed for upgrades. The commitment aligns with Azteca's planned reopening ahead of the 2026 FIFA World Cup. Mexico City officials have said that the revamped stadium will be ready in early 2026, following a multi-year overhaul to meet FIFA standards. That construction forced the NFL to pause its Mexico games from 2023 through 2025. Estadio Azteca last hosted the NFL in 2022, when the San Francisco 49ers defeated the Arizona Cardinals 38-10 on Monday Night Football. The league had staged multiple regular-season matchups there across the past two decades, including the landmark 2005 game that marked the first NFL regular-season contest played outside the United States. Specifics for the 2026 return — date, teams and broadcast details — will be announced at a later date. But Goodell's confirmation formalizes what had been widely anticipated once Azteca's timeline firmed up. The venue's upgrades include revamped player facilities and hospitality areas, along with seating changes tied to World Cup hosting. –Field Level Media

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Oct 3 (Reuters) – 4DMedical Ltd: * SECURES A$22.6 MILLION VIA OPTION EXERCISE Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Oct 2 (OPTA) – Summaries for the Serie A on Thursday (start times are BRST) Vitória (1) 1 Scorers: Zé Marcos 19 Yellow card: Cáceres 52, Ramon 86 Subs used: Matheuzinho 55 (Aitor Cantalapiedra), Osvaldo 55 (Erick), López 72 (Renato Kayzer), Pepê 72 (Ronald), Claudinho 80 (Cáceres) Ceará (0) 0 Yellow card: Vina 47 Subs used: Vina 46 (Richardson), Vinicius Zanocelo 63 (Fernando Sobral), Paulo Baya 63 (Galeano), Aylon 72 (Pedro Henrique), Mugni 82 (Lourenço) Referee: Matheus Delgado Candançan ……………………………………………………….. Fortaleza in play São Paulo ……………………………………………………….. Flamengo in play Cruzeiro ……………………………………………………….. Saturday, October 4 fixtures (BRST/GMT) Fluminense v Atlético Mineiro (2130) RB Bragantino v Grêmio (2130) Internacional v Botafogo (2130) Sunday, October 5 fixtures (BRST/GMT) Corinthians v Mirassol (0000) Vasco da Gama v Vitória (1900) São Paulo v Palmeiras (1900) Bahia v Flamengo (2130) Juventude v Fortaleza (2130) Cruzeiro v Sport Recife (2330) Ceará v Santos (2330)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

(Adds pricing details from Jazz Pharma in paragraph 6) By Siddhi Mahatole Oct 2 (Reuters) – The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals and Roche's combination therapy as a maintenance treatment for adult patients with a type of lung cancer, the regulator said on Thursday. Jazz's drug, Zepzelca, in combination with Roche's Tecentriq, is now approved for patients with extensive-stage small cell lung cancer (ES-SCLC), whose disease has not progressed after initial chemotherapy. This is an aggressive form of lung cancer that may spread to other parts of the body, including the bone marrow. "This approval marks the first and only combination therapy for the first-line maintenance treatment of ES-SCLC, a highly aggressive disease for which treatment options have been limited," Roche said in a statement. Zepzelca is already approved as a second-line treatment — to be administered when the initial treatment fails — for the illness. "With the FDA approval, the combination will be eligible for reimbursement," Jazz Pharma told Reuters. Zepzelca's list price is $8,110, according to the company website as of January 14. Jazz Pharma noted that the cost does not change per indication. The combination therapy's approval is based on late-stage trial data showing a 46% reduction in disease progression and a 27% reduction in death risk compared with Tecentriq alone. The recommended dosing regimen includes Zepzelca given every three weeks by intravenous infusion, and Tecentriq injected either intravenously every two to four weeks, or subcutaneously every three weeks, depending on the formulation, the FDA said. Roche's Tecentriq is an immunotherapy widely used to treat multiple cancer types, including non-small cell lung cancer. In May last year, Amgen's targeted immunotherapy, Imdelltra, was approved as a second-line treatment for patients whose disease has progressed after platinum-based chemotherapy. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed and Alan Barona)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

TOKYO, Oct 3 (Reuters) – Japan's jobless rate in August rose to 2.6% from 2.3% in July, government data showed on Friday. Economists' median forecast was for 2.4%. The jobs-to-applicants ratio in August inched down to 1.20 from 1.22 in the previous month. The median forecast was 1.22. (Reporting by Kentaro Sugiyama; Writing by Satoshi Sugiyama; Editing by Muralikumar Anantharaman)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)